• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Top 5 Most-Watched Interviews in 2019


In 2019, The American Journal of Managed Care® team interviewed key opinion leaders nationwide. Here are the top 5 most-watched interviews from this year.

5. Dr Nicholas Robert Explains the Benefits, Challenges of Using RWE for Measuring Clinical End Points

The use of real-world evidence (RWE) has expanded through increased access of electronic medical records, which provides physicians the ability to identify prior treatments and care given to patients. Nicholas Robert, MD, medical director of Data, Evidence & Insights, McKesson Life Sciences, discusses the benefits of RWE for measuring end points, as well as the challenges posed by variability in clinical practice.

Watch the full interview here.

4. David Ortiz Explains How OCM Is Changing Cancer Care Delivery

The Oncology Care Model (OCM) brought necessary innovations within the state of cancer care, which may further expand through the subsequent Oncology Care First slated for release in January 2021. In this interview, David Ortiz, OCM program director at Montefiore Einstein Center for Cancer Care, described how OCM is pushing cancer centers and cancer programs to make the changes they knew were needed to improve care delivery and patient experiences.

Watch the full interview here.

3. Dr Brian Koffman: It Is Critical That Patients Educate Themselves and Leverage Their Advantages

When it comes to treatment for chronic lymphocytic leukemia (CLL), physician Brian Koffman, MDCM, DCFP, DABFM, MS Ed, medical director, CLL Society, was able to leverage his medical and scientific knowledge to receive effective care. While patients may not be physicians with extensive knowledge, Koffman encourages other patients to educate themselves on their illnesses in order to receive the best care.

Watch the full interview here.

2. Dr Jeff Sharman On Using Precision Medicine to Treat CLL

CLL is divided primarily into 2 groups of patients: those who have mutated B-cell receptor, and those who have an unmutated B-cell receptor. Jeff Sharman, MD, medical oncologist, Willamette Valley Cancer Institute and Research Center; medical director, The US Oncology Network, explains how patients who are unmutated benefit more from personalized medicine, and further describes how this approach has changed the way physicians think about treatment for patients with CLL.

Watch the full interview here.

1. Abra Kelson Explains How Social Workers Help Patients Overcome Challenges

Patients often have to deal with external factors beyond their disease that can cause added anxiety and depression, such as housing concerns, transportation, and insurance coverage. Abra Kelson, MSW, LSWA-IC, medical social work supervisor, Northwest Medical Specialties, explains that standard treatment isn’t always right for everyone, and part of a social worker’s job as a member of the care team is to understand the patient’s goals and how to tailor treatment to address issues most prevalent to their care.

Watch the full interview here.

Related Videos
Dr Mrinal Gounder
Related Content
© 2023 MJH Life Sciences
All rights reserved.